The best calibre of companies resist competitive threats year-in, year-out, while their competitors fail. This cycle of consistent outperformance and reinvestment can lead to incredible compounding returns – especially in times of worl...
|Type||Buy / Hold / Sell|
|Year End 31st Dec||Unit||2016||2017||2018||2019||2020||2021E||2022E||CAGR / Avg|
|Diluted Normalised EPS|
|Op. Cashflow ps|
|Free Cashflow ps|
|Diluted Weighted Average Shares||m|
|Book Value ps|
|Leverage (ttm)||Total||- Intang||+ Pension|
|Cash / Assets|
Latest News & Insights for ALIF B
Studies by leading experts into the power of price momentum show that stocks with the strongest price trends tend to keep up the pace for anywhere up to one year. A big part of the reason for this is down to investor psychology. With...
AddLife AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company markets and sells instruments, equipment, consumables and related services mainly to the healthcare sector. The Company operates through two segments: The LabTech segment is engaged in the sales of laboratory equipment, analytical instruments and reagents, that are used for diagnostics or biomedical research; The MedTech segment offers various medical device equipment, consumables, instruments and devices, primarily to hospitals. The Company operates through number of subsidiaries, such as BergmanLabora AB, BioNordica group, Holm & Halby A/S, Immuno Diagnostic Oy, LabRobot Products AB, Triolab-group, Active Care Sverup AB, Fenno Medical Oy, Mediplast AB, among others.
Latest News for ALIF B
Upcoming Events for ALIF B
Q4 2021 AddLife AB Earnings Release
Q4 2021 AddLife AB Earnings Call
Q1 2022 AddLife AB Earnings Release
Q1 2022 AddLife AB Earnings Call
AddLife AB Annual Shareholders Meeting
Q2 2022 AddLife AB Earnings Release
Q2 2022 AddLife AB Earnings Call
As of Today at 06:02 UTC, shares in AddLife AB are trading at SEK258.80. This share price information is delayed by 15 minutes.
Shares in AddLife AB last closed at SEK258.80 and the price had moved by +72.3% over the past 365 days. In terms of relative price strength the AddLife AB share price has outperformed the FTSE Global All Cap Index by +52.33% over the past year.
The overall consensus recommendation for AddLife AB is Buy. You can view the full broker recommendation list by unlocking its StockReport.
The AddLife AB dividend yield is 0.58% based on the trailing twelve month period.
Last year, AddLife AB paid a total dividend of SEK1.50, and it currently has a trailing dividend yield of 0.58%. We do not have any data on when AddLife AB is to next pay dividends.
We do not have data on when AddLife AB is to next pay dividends. The historic dividend yield on AddLife AB shares is currently 0.58%.
To buy shares in AddLife AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of SEK258.80, shares in AddLife AB had a market capitalisation of SEK31.56bn.
Here are the trading details for AddLife AB:
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: ALIF B
Based on an overall assessment of its quality, value and momentum AddLife AB is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in AddLife AB is SEK375.00. That is 44.9% above the last closing price of SEK258.80.
Analysts covering AddLife AB currently have a consensus Earnings Per Share (EPS) forecast of SEK6.20 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like AddLife AB. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -8.11%.
As of the last closing price of SEK258.80, shares in AddLife AB were trading -12.78% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The AddLife AB PE ratio based on its reported earnings over the past 12 months is 48.83. The shares last closed at SEK258.80.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
AddLife AB's management team is headed by:
- Johan Sjo - NEC
- Kristina Willgard - PRE
- Martin Almgren - CFO
- Ove Sandin - OTH
- Peter Simonsbacka - OTH
- Stefan Hedelius - DRC
- Hakan Roos - DRC
- Andreas Gothberg - IND
- Eva Nilsagard - IND
- Birgit Norinder - IND